B4GALNT1 and Parkinson disease: The initial observation of Parkinsonism in B4GALNT1 KO mice documented loss of neurons in substantia nigra, a loss that could be substantially ameliorated by dosing animals with the semi-synthetic, brain-permeable GM1 ganglioside analog, LIGA20 (Wu et al., 2011).